Trevena, Inc. - stock earnings
TRVN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -7.9 million USD | 180000 USD |
| 2023Q2 | -8.0 million USD | 3.0 million USD |
| 2023Q1 | -6.0 million USD | 6000 USD |
| 2022Q4 | -7.5 million USD | ? USD |
| 2022Q3 | -14.8 million USD | -438000 USD |
| 2022Q2 | -15.1 million USD | ? USD |
| 2022Q1 | -16.3 million USD | 20000 USD |
| 2021Q4 | -14.0 million USD | -1000 USD |
| 2021Q3 | -13.8 million USD | 181000 USD |
| 2021Q2 | -14.0 million USD | 178000 USD |
| 2021Q1 | -9.8 million USD | 209000 USD |
| 2020Q4 | -11.9 million USD | 69000 USD |
| 2020Q3 | -5.6 million USD | 3.0 million USD |
| 2020Q2 | -6.2 million USD | ? USD |
| 2020Q1 | -5.7 million USD | 31000 USD |
| 2019Q4 | -6.4 million USD | 31000 USD |
| 2019Q3 | -8.6 million USD | ? USD |
| 2019Q2 | -4.7 million USD | ? USD |
| 2019Q1 | -5.2 million USD | 232000 USD |
| 2018Q4 | -8.0 million USD | 232000 USD |
| 2018Q3 | -4.5 million USD | 3.0 million USD |
| 2018Q2 | -9.3 million USD | 2.5 million USD |
| 2018Q1 | -9.0 million USD | ? USD |
| 2017Q4 | -14.7 million USD | ? USD |
| 2017Q3 | -16.0 million USD | ? USD |
| 2017Q2 | -20.4 million USD | ? USD |
| 2017Q1 | -20.7 million USD | ? USD |
| 2016Q4 | -36.1 million USD | 3.8 million USD |
| 2016Q3 | -29.9 million USD | 1.9 million USD |
| 2016Q2 | -19.2 million USD | 1.9 million USD |
| 2016Q1 | -17.8 million USD | 1.9 million USD |
| 2015Q4 | -15.5 million USD | 1.9 million USD |
| 2015Q3 | -10.6 million USD | 1.9 million USD |
| 2015Q2 | -11.5 million USD | 1.9 million USD |
| 2015Q1 | -12.9 million USD | 625000 USD |
| 2014Q4 | -13.3 million USD | ? USD |
| 2014Q3 | -15.5 million USD | ? USD |
| 2014Q2 | -11.5 million USD | ? USD |
| 2014Q1 | -9.4 million USD | ? USD |
| 2013Q4 | -6.9 million USD | -134980 USD |
| 2013Q3 | -8.8 million USD | 94000 USD |
| 2013Q2 | -4.7 million USD | 93779 USD |
| 2013Q1 | -2.9 million USD | 41201 USD |
| 2012Q4 | -3.1 million USD | 252635 USD |
| 2012Q3 | -4.1 million USD | 147379 USD |
| 2011Q4 | ? USD | 2.4 million USD |
TRVN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.7 million USD | 3.2 million USD |
| 2022 | -53.7 million USD | -418000 USD |
| 2021 | -51.2 million USD | 567000 USD |
| 2020 | -29.4 million USD | 3.1 million USD |
| 2019 | -28.1 million USD | 31000 USD |
| 2018 | -30.8 million USD | 5.7 million USD |
| 2017 | -71.9 million USD | ? USD |
| 2016 | -103.0 million USD | 3.8 million USD |
| 2015 | -50.5 million USD | 6.3 million USD |
| 2014 | -49.7 million USD | ? USD |
| 2013 | -23.3 million USD | 134980 USD |
| 2012 | -15.6 million USD | 807595 USD |
| 2011 | -15.8 million USD | 2.4 million USD |
TRVN
Price: $0.41
52 week price:
Earnings Per Share: -3.16 USD
P/E Ratio: -0.10
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 42100
Ebitda: -15.1 millionMarket Capitalization: 7.0 million